Cargando…

Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia

We investigated noninvasive follow‐up markers for histologic liver fibrosis and portal hypertension (PH) in patients with biliary atresia after successful portoenterostomy (PE). Among children with bilirubin <20 µmol/L after PE (n = 39), Metavir fibrosis stage was evaluated at PE and in follow‐up...

Descripción completa

Detalles Bibliográficos
Autores principales: Hukkinen, Maria, Lohi, Jouko, Heikkilä, Päivi, Kivisaari, Reetta, Jahnukainen, Timo, Jalanko, Hannu, Pakarinen, Mikko P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396371/
https://www.ncbi.nlm.nih.gov/pubmed/30859150
http://dx.doi.org/10.1002/hep4.1306
_version_ 1783399236347363328
author Hukkinen, Maria
Lohi, Jouko
Heikkilä, Päivi
Kivisaari, Reetta
Jahnukainen, Timo
Jalanko, Hannu
Pakarinen, Mikko P.
author_facet Hukkinen, Maria
Lohi, Jouko
Heikkilä, Päivi
Kivisaari, Reetta
Jahnukainen, Timo
Jalanko, Hannu
Pakarinen, Mikko P.
author_sort Hukkinen, Maria
collection PubMed
description We investigated noninvasive follow‐up markers for histologic liver fibrosis and portal hypertension (PH) in patients with biliary atresia after successful portoenterostomy (PE). Among children with bilirubin <20 µmol/L after PE (n = 39), Metavir fibrosis stage was evaluated at PE and in follow‐up protocol liver biopsies (n = 83). PH was defined as endoscopically confirmed esophageal varices or thrombocytopenia associated with splenomegaly. The accuracy of liver biochemistry and stiffness in detecting liver fibrosis and PH was analyzed by the area under the receiving operating characteristic curve (AUROC) and multiple regression models. During a median native liver survival of 8.3 years (interquartile range 2.5‐10.8 years), cirrhosis (Metavir F4) had developed in 51% of patients and PH in 54% of patients. Cirrhosis was equally common in all age tertiles of 1.2‐2.1 years (n = 10/27), 3.9‐5.8 years (n = 12/28), and 9.0‐14 years (n = 12/28). In the two oldest age tertiles, histologic liver fibrosis had progressed further in patients with PH than without PH (P < 0.001). PH was accurately predicted by the aspartate aminotransferase‐to‐platelet ratio index (APRI) (cutoff, 0.70; AUROC, 0.92), bile acids (cutoff, 49 µmol/L; AUROC, 0.91), and liver stiffness (cutoff, 16.9 kPa; AUROC, 0.89; P < 0.001 each) across all age tertiles. Liver stiffness was the most accurate predictor of cirrhosis overall (AUROC, 0.82; P < 0.001), whereas bilirubin was >11 µmol/L in the youngest tertile (AUROC, 0.91; P < 0.001), bile acids was >80 µmol/L in the middle tertile (AUROC, 0.81; P = 0.009), and liver stiffness was >24 kPa in the oldest age tertile (AUROC, 0.96; P = 0.002). Conclusion: After successful PE, development of PH associates with progression of liver fibrosis and can be accurately detected by APRI and stiffness. Liver stiffness most accurately identified cirrhosis in older children, whereas biochemical markers of cholestasis closely reflected histologic cirrhosis in younger children.
format Online
Article
Text
id pubmed-6396371
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63963712019-03-11 Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia Hukkinen, Maria Lohi, Jouko Heikkilä, Päivi Kivisaari, Reetta Jahnukainen, Timo Jalanko, Hannu Pakarinen, Mikko P. Hepatol Commun Original Articles We investigated noninvasive follow‐up markers for histologic liver fibrosis and portal hypertension (PH) in patients with biliary atresia after successful portoenterostomy (PE). Among children with bilirubin <20 µmol/L after PE (n = 39), Metavir fibrosis stage was evaluated at PE and in follow‐up protocol liver biopsies (n = 83). PH was defined as endoscopically confirmed esophageal varices or thrombocytopenia associated with splenomegaly. The accuracy of liver biochemistry and stiffness in detecting liver fibrosis and PH was analyzed by the area under the receiving operating characteristic curve (AUROC) and multiple regression models. During a median native liver survival of 8.3 years (interquartile range 2.5‐10.8 years), cirrhosis (Metavir F4) had developed in 51% of patients and PH in 54% of patients. Cirrhosis was equally common in all age tertiles of 1.2‐2.1 years (n = 10/27), 3.9‐5.8 years (n = 12/28), and 9.0‐14 years (n = 12/28). In the two oldest age tertiles, histologic liver fibrosis had progressed further in patients with PH than without PH (P < 0.001). PH was accurately predicted by the aspartate aminotransferase‐to‐platelet ratio index (APRI) (cutoff, 0.70; AUROC, 0.92), bile acids (cutoff, 49 µmol/L; AUROC, 0.91), and liver stiffness (cutoff, 16.9 kPa; AUROC, 0.89; P < 0.001 each) across all age tertiles. Liver stiffness was the most accurate predictor of cirrhosis overall (AUROC, 0.82; P < 0.001), whereas bilirubin was >11 µmol/L in the youngest tertile (AUROC, 0.91; P < 0.001), bile acids was >80 µmol/L in the middle tertile (AUROC, 0.81; P = 0.009), and liver stiffness was >24 kPa in the oldest age tertile (AUROC, 0.96; P = 0.002). Conclusion: After successful PE, development of PH associates with progression of liver fibrosis and can be accurately detected by APRI and stiffness. Liver stiffness most accurately identified cirrhosis in older children, whereas biochemical markers of cholestasis closely reflected histologic cirrhosis in younger children. John Wiley and Sons Inc. 2019-01-09 /pmc/articles/PMC6396371/ /pubmed/30859150 http://dx.doi.org/10.1002/hep4.1306 Text en © 2019 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Hukkinen, Maria
Lohi, Jouko
Heikkilä, Päivi
Kivisaari, Reetta
Jahnukainen, Timo
Jalanko, Hannu
Pakarinen, Mikko P.
Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia
title Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia
title_full Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia
title_fullStr Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia
title_full_unstemmed Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia
title_short Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia
title_sort noninvasive evaluation of liver fibrosis and portal hypertension after successful portoenterostomy for biliary atresia
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396371/
https://www.ncbi.nlm.nih.gov/pubmed/30859150
http://dx.doi.org/10.1002/hep4.1306
work_keys_str_mv AT hukkinenmaria noninvasiveevaluationofliverfibrosisandportalhypertensionaftersuccessfulportoenterostomyforbiliaryatresia
AT lohijouko noninvasiveevaluationofliverfibrosisandportalhypertensionaftersuccessfulportoenterostomyforbiliaryatresia
AT heikkilapaivi noninvasiveevaluationofliverfibrosisandportalhypertensionaftersuccessfulportoenterostomyforbiliaryatresia
AT kivisaarireetta noninvasiveevaluationofliverfibrosisandportalhypertensionaftersuccessfulportoenterostomyforbiliaryatresia
AT jahnukainentimo noninvasiveevaluationofliverfibrosisandportalhypertensionaftersuccessfulportoenterostomyforbiliaryatresia
AT jalankohannu noninvasiveevaluationofliverfibrosisandportalhypertensionaftersuccessfulportoenterostomyforbiliaryatresia
AT pakarinenmikkop noninvasiveevaluationofliverfibrosisandportalhypertensionaftersuccessfulportoenterostomyforbiliaryatresia